Treatment if hibernating myocardium and diabetic cordiomyopathy with a GLP-1 peptide

Details for Australian Patent Application No. 2004229049 (hide)

Owner Amylin Pharmaceuticals, Inc.

Inventors Coolidge, Thomas R.; Ehlers, Mario

Agent Davies Collison Cave

Pub. Number AU-A-2004229049

Parent 775663

Filing date 11 November 2004

Wipo publication date 9 December 2004

Acceptance publication date 1 November 2007

International Classifications

A61K 038/26 Medicinal preparations containing peptides - Glucagons

A61P 009/10 Drugs for disorders of the cardiovascular system

Event Publications

25 November 2004 Complete Application Filed

9 December 2004 Application Open to Public Inspection

  Published as AU-A-2004229049

23 December 2004 Amendment Made

  The nature of the amendment is: Amend the invention title to read Treatment Of Hibernating Myocardium Or Pulmonary Congestion.

1 November 2007 Application Accepted

  Published as AU-A-2004229049

28 February 2008 Standard Patent Sealed

31 July 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 04 Jul 2008. Address for service in Australia - Davies Collison Cave Level 15 1 Nicholson Street Melbourne VIC 3000

11 December 2008 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 04 Jul 2008

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004229050-VIPCom2VIPCom Communications

2004229048-Method and apparatus for multi-sensory speech enhancement